Cargando…
Defining the Protease and Protease Inhibitor (P/PI) Proteomes of Healthy and Diseased Human Skin by Modified Systematic Review
Proteases and protease inhibitors (P/PIs) are involved in many biological processes in human skin, yet often only specific families or related groups of P/PIs are investigated. Proteomics approaches, such as mass spectrometry, can define proteome signatures (including P/PIs) in tissues; however, the...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946613/ https://www.ncbi.nlm.nih.gov/pubmed/35327667 http://dx.doi.org/10.3390/biom12030475 |
_version_ | 1784674235917008896 |
---|---|
author | Stewart-McGuinness, Callum Platt, Christopher I. Ozols, Matiss Goh, Brian Griffiths, Tamara W. Sherratt, Michael J. |
author_facet | Stewart-McGuinness, Callum Platt, Christopher I. Ozols, Matiss Goh, Brian Griffiths, Tamara W. Sherratt, Michael J. |
author_sort | Stewart-McGuinness, Callum |
collection | PubMed |
description | Proteases and protease inhibitors (P/PIs) are involved in many biological processes in human skin, yet often only specific families or related groups of P/PIs are investigated. Proteomics approaches, such as mass spectrometry, can define proteome signatures (including P/PIs) in tissues; however, they struggle to detect low-abundance proteins. To overcome these issues, we aimed to produce a comprehensive proteome of all P/PIs present in normal and diseased human skin, in vivo, by carrying out a modified systematic review using a list of P/PIs from MEROPS and combining this with key search terms in Web of Science. Resulting articles were manually reviewed against inclusion/exclusion criteria and a dataset constructed. This study identified 111 proteases and 77 protease inhibitors in human skin, comprising the serine, metallo-, cysteine and aspartic acid catalytic families of proteases. P/PIs showing no evidence of catalytic activity or protease inhibition, were designated non-peptidase homologs (NPH), and no reported protease inhibitory activity (NRPIA), respectively. MMP9 and TIMP1 were the most frequently published P/PIs and were reported in normal skin and most skin disease groups. Normal skin and diseased skin showed significant overlap with respect to P/PI profile; however, MMP23 was identified in several skin disease groups, but was absent in normal skin. The catalytic profile of P/PIs in wounds, scars and solar elastosis was distinct from normal skin, suggesting that a different group of P/PIs is responsible for disease progression. In conclusion, this study uses a novel approach to provide a comprehensive inventory of P/PIs in normal and diseased human skin reported in our database. The database may be used to determine either which P/PIs are present in specific diseases or which diseases individual P/PIs may influence. |
format | Online Article Text |
id | pubmed-8946613 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89466132022-03-25 Defining the Protease and Protease Inhibitor (P/PI) Proteomes of Healthy and Diseased Human Skin by Modified Systematic Review Stewart-McGuinness, Callum Platt, Christopher I. Ozols, Matiss Goh, Brian Griffiths, Tamara W. Sherratt, Michael J. Biomolecules Article Proteases and protease inhibitors (P/PIs) are involved in many biological processes in human skin, yet often only specific families or related groups of P/PIs are investigated. Proteomics approaches, such as mass spectrometry, can define proteome signatures (including P/PIs) in tissues; however, they struggle to detect low-abundance proteins. To overcome these issues, we aimed to produce a comprehensive proteome of all P/PIs present in normal and diseased human skin, in vivo, by carrying out a modified systematic review using a list of P/PIs from MEROPS and combining this with key search terms in Web of Science. Resulting articles were manually reviewed against inclusion/exclusion criteria and a dataset constructed. This study identified 111 proteases and 77 protease inhibitors in human skin, comprising the serine, metallo-, cysteine and aspartic acid catalytic families of proteases. P/PIs showing no evidence of catalytic activity or protease inhibition, were designated non-peptidase homologs (NPH), and no reported protease inhibitory activity (NRPIA), respectively. MMP9 and TIMP1 were the most frequently published P/PIs and were reported in normal skin and most skin disease groups. Normal skin and diseased skin showed significant overlap with respect to P/PI profile; however, MMP23 was identified in several skin disease groups, but was absent in normal skin. The catalytic profile of P/PIs in wounds, scars and solar elastosis was distinct from normal skin, suggesting that a different group of P/PIs is responsible for disease progression. In conclusion, this study uses a novel approach to provide a comprehensive inventory of P/PIs in normal and diseased human skin reported in our database. The database may be used to determine either which P/PIs are present in specific diseases or which diseases individual P/PIs may influence. MDPI 2022-03-20 /pmc/articles/PMC8946613/ /pubmed/35327667 http://dx.doi.org/10.3390/biom12030475 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Stewart-McGuinness, Callum Platt, Christopher I. Ozols, Matiss Goh, Brian Griffiths, Tamara W. Sherratt, Michael J. Defining the Protease and Protease Inhibitor (P/PI) Proteomes of Healthy and Diseased Human Skin by Modified Systematic Review |
title | Defining the Protease and Protease Inhibitor (P/PI) Proteomes of Healthy and Diseased Human Skin by Modified Systematic Review |
title_full | Defining the Protease and Protease Inhibitor (P/PI) Proteomes of Healthy and Diseased Human Skin by Modified Systematic Review |
title_fullStr | Defining the Protease and Protease Inhibitor (P/PI) Proteomes of Healthy and Diseased Human Skin by Modified Systematic Review |
title_full_unstemmed | Defining the Protease and Protease Inhibitor (P/PI) Proteomes of Healthy and Diseased Human Skin by Modified Systematic Review |
title_short | Defining the Protease and Protease Inhibitor (P/PI) Proteomes of Healthy and Diseased Human Skin by Modified Systematic Review |
title_sort | defining the protease and protease inhibitor (p/pi) proteomes of healthy and diseased human skin by modified systematic review |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946613/ https://www.ncbi.nlm.nih.gov/pubmed/35327667 http://dx.doi.org/10.3390/biom12030475 |
work_keys_str_mv | AT stewartmcguinnesscallum definingtheproteaseandproteaseinhibitorppiproteomesofhealthyanddiseasedhumanskinbymodifiedsystematicreview AT plattchristopheri definingtheproteaseandproteaseinhibitorppiproteomesofhealthyanddiseasedhumanskinbymodifiedsystematicreview AT ozolsmatiss definingtheproteaseandproteaseinhibitorppiproteomesofhealthyanddiseasedhumanskinbymodifiedsystematicreview AT gohbrian definingtheproteaseandproteaseinhibitorppiproteomesofhealthyanddiseasedhumanskinbymodifiedsystematicreview AT griffithstamaraw definingtheproteaseandproteaseinhibitorppiproteomesofhealthyanddiseasedhumanskinbymodifiedsystematicreview AT sherrattmichaelj definingtheproteaseandproteaseinhibitorppiproteomesofhealthyanddiseasedhumanskinbymodifiedsystematicreview |